{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:19:05Z","timestamp":1772785145411,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.ejphar.2019.172527","type":"journal-article","created":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T11:12:12Z","timestamp":1562325132000},"page":"172527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Expression of metabotropic glutamate 5 receptors in the striatum and cortex and effects of modulators on the severity of dystonia in the phenotypic dt model"],"prefix":"10.1016","volume":"859","author":[{"given":"Stefanie","family":"Perl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franziska","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birthe","family":"Gericke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelika","family":"Richter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2019.172527_bib1","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/mds.25475","article-title":"Phenomenology and classification of dystonia: a consensus update","volume":"8","author":"Albanese","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2019.172527_bib2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.neuropharm.2009.01.002","article-title":"Metabotropic glutamate receptor-dependent long-term potentiation","volume":"56","author":"Anwyl","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2019.172527_bib3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.expneurol.2014.08.012","article-title":"Role of striatal NMDA receptor subunits in a model of paroxysmal dystonia","volume":"261","author":"Avchalumov","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2019.172527_bib4","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pneurobio.2015.07.002","article-title":"Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease","volume":"132","author":"Bastide","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2019.172527_bib5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.expneurol.2016.10.013","article-title":"Altered postnatal maturation of striatal GABAergic interneurons in a phenotypic animal model of dystonia","volume":"287","author":"Bode","year":"2017","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2019.172527_bib6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nrn1763","article-title":"Metabotropic glutamate receptors in the basal ganglia motor circuit","volume":"6","author":"Conn","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.ejphar.2019.172527_bib7","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pharmthera.2005.01.008","article-title":"Regulation of metabotropic glutamate receptor signaling, desensitization and endocytosis","volume":"111","author":"Dhami","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2019.172527_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.46","article-title":"mRNA and protein expression for novel GABAA receptors \u03b8 and \u03c12 are altered in schizophrenia and mood disorders; relevance to FMRP-mGluR5 signaling pathway","volume":"3","author":"Fatemi","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.ejphar.2019.172527_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0006-8993(99)01080-X","article-title":"Alterations in spontaneous single unit activity of striatal subdivisions during ontogenesis in mutant dystonic hamsters","volume":"821","author":"Gernert","year":"1999","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2019.172527_bib10","doi-asserted-by":"crossref","first-page":"7052","DOI":"10.1523\/JNEUROSCI.20-18-07052.2000","article-title":"Deficit of striatal parvalbumin-reactive GABAergic interneurons and decreased basal ganglia output in a genetic rodent model of idiopathic paroxysmal dystonia","volume":"20","author":"Gernert","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2019.172527_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuroscience.2017.05.051","article-title":"Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dtsz) hamster and moderate antidystonic efficacy of M1 and M4 anticholinergics","volume":"357","author":"Hamann","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2019.172527_bib12","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.neuroscience.2010.06.023","article-title":"Chronic corticosterone administration down-regulates metabotropic glutamate receptor 5 protein expression in the rat hippocampus","volume":"169","author":"Iyo","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2019.172527_bib13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuropharm.2009.04.011","article-title":"The anxiolytic and analgesic properties of fenobam, a potent mGlu5 receptor antagonist, in relation to the impairment of learning","volume":"57","author":"Jacob","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2019.172527_bib14","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1517\/17460441.3.1.83","article-title":"Animal models for drug discovery in dystonia","volume":"3","author":"Jinnah","year":"2008","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.ejphar.2019.172527_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/jpet.104.079244","article-title":"A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models","volume":"313","author":"Kinney","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.172527_bib16","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.nbd.2004.01.012","article-title":"Increased excitability in cortico-striatal synaptic pathway in a model of paroxysmal dystonia","volume":"16","author":"K\u00f6hling","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2019.172527_bib17","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.neuropharm.2016.03.036","article-title":"Metabotropic glutamate receptors as therapeutic targets in Parkinson's disease: an update from the last 5 years of research","volume":"115","author":"Litim","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2019.172527_bib18","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.0953-816x.2001.01843.x","article-title":"Pharmacological validation of behavioural measures of akinesia and dyskinesia in a rat model of Parkinson's disease","volume":"15","author":"Lundblad","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejphar.2019.172527_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1006\/exnr.2002.7932","article-title":"Changes in AMPA receptor binding in an animal model of inborn paroxysmal dystonia","volume":"176","author":"Nobrega","year":"2002","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2019.172527_bib20","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.neurobiolaging.2009.07.014","article-title":"Metabotropic glutamate receptor type 5 in levodopa-induced motor complications","volume":"32","author":"Ouattara","year":"2011","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.ejphar.2019.172527_bib21","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1113\/jphysiol.2014.272773","article-title":"Contrasting actions of group I metabotropic glutamate receptors in distinct mouse striatal neurones","volume":"592","author":"Partridge","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2019.172527_bib22","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.nucmedbio.2007.07.009","article-title":"Species differences in mGluR5 binding sites in mammalian central nervous system determined using in vitro binding with [18F]F-PEB","volume":"34","author":"Patel","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.ejphar.2019.172527_bib23","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.nbd.2009.12.003","article-title":"Convergent evidence for abnormal striatal synaptic plasticity in dystonia","volume":"37","author":"Peterson","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2019.172527_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1124\/jpet.105.089839","article-title":"Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity","volume":"315","author":"Porter","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2019.172527_bib25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.parkreldis.2014.05.003","article-title":"Use of metabotropic glutamate 5-receptor antagonists for treatment of levodopa-induced dyskinesias","volume":"20","author":"Rascol","year":"2014","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ejphar.2019.172527_bib26","series-title":"Animal Models of Movement Disorders","first-page":"459","article-title":"The genetically dystonic hamster: an animal model of paroxysmal dystonia","author":"Richter","year":"2005"},{"key":"10.1016\/j.ejphar.2019.172527_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-2999(93)90691-A","article-title":"Alterations in pharmacological sensitivity on GABAergic, but not dopaminergic and glutaminergic systems during ontogenesis in dystonic mutant hamsters","volume":"231","author":"Richter","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172527_bib28","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S0006-8993(97)00720-8","article-title":"MK-801 potentiates antidystonic effects of clozapine but not of haloperidol in mutant dystonic hamsters","volume":"769","author":"Richter","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2019.172527_bib29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0301-0082(97)00089-0","article-title":"Pathophysiology of idiopathic dystonia: findings from genetic animal models","volume":"54","author":"Richter","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2019.172527_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pneurobio.2014.07.002","article-title":"Genetic animal models of dystonia: common features and diversities","volume":"121C","author":"Richter","year":"2014","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejphar.2019.172527_bib31","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-2999(93)90462-Q","article-title":"The AMPA receptor antagonist NBQX exerts antidystonic effects in an animal model of idiopathic dystonia","volume":"231","author":"Richter","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172527_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ejphar.2010.02.057","article-title":"Functional interaction of metabotropic glutamate receptor 5 and NMDA\u2010receptor by a metabotropic glutamate receptor 5 positive allosteric modulator","volume":"639","author":"Rosenbrock","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172527_bib33","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.nbd.2010.05.001","article-title":"A mGluR5 antagonist under clinical development improves L-DOPA-induced dyskinesia in parkinsonian rats and monkeys","volume":"39","author":"Rylander","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejphar.2019.172527_bib34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ejphar.2007.01.067","article-title":"Effects of intrastriatal injections of glutamate receptor antagonists on the severity of paroxysmal dystonia in the dtsz mutant","volume":"563","author":"Sander","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.172527_bib35","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.neuropharm.2011.10.016","article-title":"Retigabine, a Kv7 (KCNQ) potassium channel opener, attenuates L-DOPA-induced dyskinesias in 6-OHDA-lesioned rats","volume":"62","author":"Sander","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2019.172527_bib36","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.neuropharm.2014.06.013","article-title":"Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia","volume":"85","author":"Sciamanna","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejphar.2019.172527_bib37","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1523\/JNEUROSCI.22-10-03910.2002","article-title":"Receptor activation and homer differentially control the lateral mobility of metabotropic glutamate receptor 5 in the neuronal membrane","volume":"22","author":"Serg\u00e9","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2019.172527_bib38","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1074\/jbc.M116.757724","article-title":"Sequences within the C terminus of the metabotropic glutamate receptor 5 (mGluR5) are responsible for inner nuclear membrane localization","volume":"292","author":"Sergin","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2019.172527_bib39","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.neuropharm.2009.07.022","article-title":"Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus","volume":"57","author":"Uslaner","year":"2009","journal-title":"Neuropharmacology"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919304790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919304790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:30:57Z","timestamp":1757975457000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919304790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":39,"alternative-id":["S0014299919304790"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172527","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of metabotropic glutamate 5 receptors in the striatum and cortex and effects of modulators on the severity of dystonia in the phenotypic dtsz model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.172527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172527"}}